Stocks Health care NEPH
NASDAQ · Health careNephros Inc (NEPH)
Nephros Inc brought in $20.7M of revenue over the twelve months to June 30, 2026, up 24.2% from a year earlier. Net income was $1.7M, a net margin of 8.4%. At June 30, 2026 it held $4.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
What Nephros Inc does
Nephros Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NEPH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $18.8M | $1.2M | $0.11 | n/a |
| 2024 | $14.2M | $74K | $0.01 | -$547K |
| 2023 | $14.2M | -$1.6M | -$0.15 | $752K |
| 2022 | $10M | -$7.4M | -$0.73 | -$3.4M |
| 2021 | $10.2M | -$3.9M | -$0.41 | -$1.5M |
| 2020 | $8.6M | -$4.5M | -$0.52 | -$7.1M |
Latest SEC filings
What Nephros Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 16, 2026Activist stake changed SCHEDULE 13D/A
- September 16, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- June 15, 2026
- May 7, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026
- April 30, 2026Annual report (amended) 10-K/A · period to December 31, 2025
- March 27, 2026
- March 12, 2026Annual report 10-K · period to December 31, 2025
Questions about NEPH
What does Nephros Inc do?
Nephros Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NEPH.
Is Nephros Inc profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $1.7M on revenue of $20.7M, a net margin of 8.4%.
How much revenue does Nephros Inc make?
Over the twelve months to June 30, 2026 Nephros Inc reported revenue of $20.7M. That is 24.2% more than a year earlier.
When did Nephros Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the activist stake changed from September 16, 2026.
Similar companies
Follow NEPH
Get an email when Nephros Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow NEPH: get an email when it filesWhere the numbers come from
Financial figures are the values Nephros Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.